The fifth edition of the (DSM-5) changed the term “somatoform disorders” to “somatic symptom and related disorders” and further modified diagnostic labels and criteria. We review evidence for the validity of the new criteria, specifically of somatic symptom disorder (SSD), and present a critical discussion of unsolved and new problems. We also provide an update of mechanisms and interventions that have been empirically evaluated in somatoform disorders. For many mechanisms, it is unclear whether their role can be easily transposed to SSD. Therefore more research is needed on the similarities and differences between medically unexplained and medically explained conditions. To overcome the obvious shortcomings of the current classification, we offer a modification of this DSM-5 section as well as a crossover system to apply these criteria for somatic symptom and related disorders. This proposal allows working with DSM-5 but also continuing successful lines of research with concepts such as hypochondriasis/illness anxiety, chronic pain, and medically unexplained versus medically explained syndromes.


Article metrics loading...

Loading full text...

Full text loading...


Literature Cited

  1. Agar-Wilson M, Jackson T. 2012. Are emotion regulation skills related to adjustment among people with chronic pain, independent of pain coping?. Eur. J. Pain 16:1105–14 [Google Scholar]
  2. Aggarwal VR, McFarlane GJ, Farragher TM, McBeth J. 2010. Risk factors for onset of chronic oro-facial pain—results of the North Cheshire oro-facial pain prospective population study. Pain 149:354–59 [Google Scholar]
  3. Allen LA, Woolfolk RL. 2013. Somatization and conversion disorder. A CBT Reference Guide 2 W Rief New York: Wiley. In press [Google Scholar]
  4. Am. Psychiatr. Assoc 2013. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: Am. Psychiatr. Publ, 5th ed..
  5. Bach M, Bach D. 1995. Predictive value of alexithymia: a prospective study in somatizing patients. Psychother. Psychosom. 64:43–48 [Google Scholar]
  6. Bailer J, Witthöft M, Rist F. 2008. Psychological predictors of short- and medium-term outcome in individuals with idiopathic environmental intolerance (IEI) and individuals with somatoform disorders. J. Toxicol. Environ. Health Part A 71:766–75 [Google Scholar]
  7. Bantick SJ, Wise RG, Ploghaus A, Clare S, Smith SM, Tracey I. 2002. Imaging how attention modulates pain in humans using functional MRI. Brain 125:310–19 [Google Scholar]
  8. Barrett B, Tyrer P, Tyrer H, Cooper S, Crawford MJ, Byford S. 2012. An examination of the factors that influence costs in medical patients with health anxiety. J. Psychosom. Res. 73:59–62 [Google Scholar]
  9. Barsky AJ, Ahern DK. 2004. Cognitive behavior therapy for hypochondriasis. A randomized controlled trial. J. Am. Med. Assoc. 291:1464–70 [Google Scholar]
  10. Barsky AJ, Orav J, Bates DW. 2005. Somatization increases medical utilization and costs independent of psychiatric and medical morbidity. Arch. Gen. Psychiatry 62:903–10 [Google Scholar]
  11. Barsky AJ, Wool C, Barnett MC, Cleary PD. 1994. Histories of childhood trauma in adult hypochondriacal patients. Am. J. Psychiatry 151:397–401 [Google Scholar]
  12. Barsky AJ, Wyshak GL. 1990. Hypochondriasis and somatosensory amplification. Br. J. Psychiatry 157:404–9 [Google Scholar]
  13. Barsky AJ, Wyshak G, Klerman GL. 1990. The somatosensory amplification scale and its relationship to hypochondriasis. J. Psychiatr. Res. 24:323–33 [Google Scholar]
  14. Bernstein MJ, Claypool HM. 2012. Social exclusion and pain sensitivity: Why exclusion sometimes hurts and sometimes numbs. Personal. Soc. Psychol. Bull. 38:185–96 [Google Scholar]
  15. Bogaerts K, Janssens T, De Peuter S, Van Diest I, Van den Bergh O. 2010a. Negative affective pictures can elicit physical symptoms in high habitual symptom reporters. Psychol. Health 25:685–98 [Google Scholar]
  16. Bogaerts K, Van Eylen L, Li W, Bresseleers J, Van Diest I. et al. 2010b. Distorted symptom perception in patients with medically unexplained symptoms. J. Abnorm. Psychol. 119:226–34 [Google Scholar]
  17. Bogaerts K, Wan L, Diest IV, Stans L, Decramer M, Van den Bergh O. 2012. Peak-end memory bias in laboratory-induced dyspnea: a comparison of patients with medically unexplained symptoms and healthy controls. Psychosom. Med. 74:974–81 [Google Scholar]
  18. Bohn D, Bernardy K, Wolfe F, Hauser W. 2013. The association among childhood maltreatment, somatic symptom intensity, depression, and somatoform dissociative symptoms in patients with fibromyalgia syndrome: a single-center cohort study. J. Trauma Dissociation 14:342–58 [Google Scholar]
  19. Bradford K, Shih W, Videlock EJ, Presson AP, Naliboff BD. et al. 2012. Association between early adverse life events and irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 10:385–90.e3 [Google Scholar]
  20. Brown RJ. 2004. Psychological mechanisms of medically unexplained symptoms: an integrative conceptual model. Psychol. Bull. 130:793–812 [Google Scholar]
  21. Brown RJ, Brunt N, Poliakoff E, Lloyd DM. 2010. Illusory touch and tactile perception in somatoform dissociators. J. Psychosom. Res. 69:241–48 [Google Scholar]
  22. Brown RJ, Skehan D, Chapman A, Perry EP, McKenzie KJ. et al. 2012. Physical symptom reporting is associated with a tendency to experience somatosensory distortion. Psychosom. Med. 74:648–55 [Google Scholar]
  23. Browning M, Fletcher P, Sharpe M. 2011. Can neuroimaging help us to understand and classify somatoform disorders? A systematic and critical review. Psychosom. Med. 73:173–84 [Google Scholar]
  24. Burton C, Weller D, Sharpe M. 2009. Functional somatic symptoms and psychological states: an electronic diary study. Psychosom. Med. 71:77–78 [Google Scholar]
  25. Cella M, White PD, Sharpe M, Chalder T. 2013. Cognitions, behaviours and comorbid psychiatric diagnoses in patients with chronic fatigue syndrome. Psychol. Med. 43:375–80 [Google Scholar]
  26. Chou R, Shekelle P. 2010. Will this patient develop persistent disabling low back pain?. J. Am. Med. Assoc. 303:1295–302 [Google Scholar]
  27. Clark DM, Salkovskis PM, Hackman A, Wells A, Fennell M. et al. 1998. Two psychological treatments for hypochondriasis. Br. J. Psychiatry 173:218–25 [Google Scholar]
  28. Cloitre M, Miranda R, Stovall-McClough KC, Han H. 2005. Beyond PTSD: emotion regulation and interpersonal problems as predictors of functional impairment in survivors of childhood abuse. Behav. Ther. 36:2119–24 [Google Scholar]
  29. Colloca L, Benedetti F. 2009. Placebo analgesia induced by social observational learning. Pain 144:28–34 [Google Scholar]
  30. Colloca L, Petrovic P, Wager TD, Ingvar M, Benedetti F. 2010. How the number of learning trials affects placebo and nocebo responses. Pain 151:430–39 [Google Scholar]
  31. Colloca L, Sigaudo M, Benedetti F. 2008. The role of learning in nocebo and placebo effects. Pain 136:211–18 [Google Scholar]
  32. Connelly M, Keefe FJ, Affleck G, Lumley MA, Anderson T, Waters S. 2007. Effects of day-to-day affect regulation on the pain experience of patients with rheumatoid arthritis. Pain 131:1–2162–70 [Google Scholar]
  33. Constantinou E, Bogaerts K, Van Diest I, Van den Bergh O. 2013. Inducing symptoms in high symptom reporters via emotional pictures: the interactive effects of valence and arousal. J. Psychosom. Res. 74:191–96 [Google Scholar]
  34. Creed F, Guthrie E, Fink P, Henningsen P, Rief W. et al. 2010. Is there a better term than “medically unexplained symptoms”?. J. Psychosom. Res. 68:5–8 [Google Scholar]
  35. Creed FH, Davies I, Jackson J, Littlewood A, Chew-Graham C. et al. 2012. The epidemiology of multiple somatic symptoms. J. Psychosom. Res. 72:311–17 [Google Scholar]
  36. Crichton F, Dodd G, Schmid G, Gamble G, Petrie KJ. 2013. Can expectations produce symptoms from infrasound associated with wind turbines?. Health Psychol. In press
  37. Davis KD, Moayedi M. 2013. Central mechanisms of pain revealed through functional and structural MRI. J. Neuroimmune Pharmacol. 8:518–34 [Google Scholar]
  38. de Jong JR, Vlaeyen JW, van Eijsden M, Loo C, Onghena P. 2012. Reduction of pain-related fear and increased function and participation in work-related upper extremity pain (WRUEP): effects of exposure in vivo. Pain 153:2109–18 [Google Scholar]
  39. Dimsdale J, Sharma N, Sharpe M. 2011. What do physicians think of somatoform disorders?. Psychosomatics 52:154–59 [Google Scholar]
  40. Dimsdale JE. 2011. Medically unexplained symptoms: a treacherous foundation for somatoform disorders?. Psychiatr. Clin. North Am. 34:511–13 [Google Scholar]
  41. Dimsdale JE, Creed F, Escobar J, Sharpe M, Wulsin L. et al. 2013. Somatic symptom disorder: an important change in DSM. J. Psychosom. Res. 75:223–28 [Google Scholar]
  42. Enck P, Bingel U, Schedlowski M, Rief W. 2013. The placebo response in medicine: minimize, maximize or personalize?. Nat. Rev. Drug Discov. 12:191–204 [Google Scholar]
  43. Escobar JI, Cook B, Chen C-N, Gara MA, Alegría M. et al. 2010. Whether medically unexplained or not, three or more concurrent somatic symptoms predict psychopathology and service use in community populations. J. Psychosom. Res. 69:1–8 [Google Scholar]
  44. Fink P, Rosendal M, Olesen F. 2005. Classification of somatization and functional somatic symptoms in primary care. Aust. N. Z. J. Psychiatry 39:772–81 [Google Scholar]
  45. Fink P, Schröder A. 2010. One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders. J. Psychosom. Res. 68:415–26 [Google Scholar]
  46. Fink P, Toft T, Hansen MS, Ornbol E, Olesen F. 2007. Symptoms and syndromes of bodily distress: an exploratory study of 978 internal medical, neurological, and primary care patients. Psychosom. Med. 69:30–39 [Google Scholar]
  47. Frances A. 2013a. DSM-5 somatic symptom disorder. J. Nerv. Ment. Dis. 201:530–31 [Google Scholar]
  48. Frances A. 2013b. Personal view. The new somatic symptom disorder in DSM-5 risks mislabeling many people as mentally ill. Br. Med. J. 346:f1580 [Google Scholar]
  49. Frances AJ, Widiger T. 2012. Psychiatric diagnosis: lessons from the DSM-IV past and cautions for the DSM-5 future. Annu. Rev. Clin. Psychol. 8:109–30 [Google Scholar]
  50. Geisser ME, Casey KL, Brucksch CB, Ribbens CM, Appleton BB, Crofford LJ. 2003. Perception of noxious and innocuous heat stimulation among healthy women and women with fibromyalgia: association with mood, somatic focus, and catastrophizing. Pain 102:243–50 [Google Scholar]
  51. Glombiewski JA, Hartwich-Tersek J, Rief W. 2010a. Two psychological interventions are effective in severely disabled, chronic back pain patients: a randomised controlled trial. Int. J. Behav. Med. 17:97–107 [Google Scholar]
  52. Glombiewski JA, Sawyer AT, Gutermann J, Koenig K, Rief W, Hofmann SG. 2010b. Psychological treatments for fibromyalgia: a meta-analysis. Pain 151:280–95 [Google Scholar]
  53. Goedendorp MM, Gielissen MF, Verhagen CA, Bleijenberg G. 2013. Development of fatigue in cancer survivors: a prospective follow-up study from diagnosis into the year after treatment. J. Pain Symptom Manag. 45:213–22 [Google Scholar]
  54. Gropalis M, Bleichhardt G, Hiller W, Witthöft M. 2012. Specificity and modifiability of cognitive biases in hypochondriasis. J. Consult. Clin. Psychol. 81:31–8 [Google Scholar]
  55. Gulec MY, Altintas M, Inanc L, Bezgin CH, Koca EK, Gulec H. 2013. Effects of childhood trauma on somatization in major depressive disorder: the role of alexithymia. J. Affect. Disord. 146:137–41 [Google Scholar]
  56. Hadjistavropoulos HD, Hadjistavropoulos T. 2003. The relevance of health anxiety to chronic pain: research findings and recommendations for assessment and treatment. Curr. Pain Headache Rep. 7:98–104 [Google Scholar]
  57. Haukka E, Kaila-Kangas L, Ojajarvi A, Miranda H, Karppinen J. et al. 2013. Pain in multiple sites and sickness absence trajectories: a prospective study among Finns. Pain 154:306–12 [Google Scholar]
  58. Hedman E, Andersson G, Andersson E, Ljotsson B, Ruck C. et al. 2011. Internet-based cognitive-behavioural therapy for severe health anxiety: randomised controlled trial. Br. J. Psychiatry 198:3230–36 [Google Scholar]
  59. Heim C, Mletzko T, Purselle D, Musselman DL, Nemeroff CB. 2008a. The dexamethasone/corticotropin-releasing factor test in men with major depression: role of childhood trauma. Biol. Psychiatry 63:398–405 [Google Scholar]
  60. Heim C, Newport DJ, Mletzko T, Miller AH, Hemeroff CB. 2008b. The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology 33:693–710 [Google Scholar]
  61. Henningsen P, Jakobsen T, Schiltenwolf M, Weiss MG. 2005. Somatization revisited–diagnosis and perceived causes of common mental disorders. J. Nerv. Ment. Dis. 193:85–92 [Google Scholar]
  62. Henningsen P, Zipfel S, Herzog W. 2007. Management of functional somatic syndromes. Lancet 369:946–55 [Google Scholar]
  63. Hiller W, Cebulla M, Korn HJ, Leibbrand R, Roers B, Nilges P. 2010. Causal symptom attributions in somatoform disorder and chronic pain. J. Psychosom. Res. 68:9–19 [Google Scholar]
  64. Hiller W, Rief W, Brähler E. 2006. Somatization in the population: from mild bodily misperceptions to disabling symptoms. Soc. Psychiatry Psychiatr. Epidemiol. 41:704–12 [Google Scholar]
  65. Horne R, Faasse K, Cooper V, Diefenbach MA, Leventhal H. et al. 2013. The perceived sensitivity to medicines (PSM) scale: an evaluation of validity and reliability. Br. J. Health Psychol. 18:18–30 [Google Scholar]
  66. Huijbregts KM, Jong FJ, van Marwijk HW, Beekman AT, Adèr HJ, van der Feltz-Cornelis CM. 2013. A high physical symptom count reduces the effectiveness of treatment for depression, independently of chronic medical conditions. J. Psychosom. Res. 74:179–85 [Google Scholar]
  67. Jasper F, Witthöft M. 2013. Automatic evaluative processes in health anxiety and their relations to emotion regulation. Cogn. Ther. Res. 37:521–33 [Google Scholar]
  68. Jensen OK, Nielsen CV, Stengaard-Pedersen K. 2010. One-year prognosis in sick-listed low back pain patients with and without radiculopathy. Prognostic factors influencing pain and disability. Spine J. 10:659–75 [Google Scholar]
  69. Kahn RS, Skapinakis P, Ahmed K, Stefanou DC, Ashraflan H. et al. 2012. The association between preoperative pain, catastrophizing and postoperative pain intensity in cardiac surgery patients. Pain Med. 13:820–27 [Google Scholar]
  70. Katzer A, Oberfeld D, Hiller W, Gerlach AL, Witthöft M. 2012. Tactile perceptual processes and their relationship to somatoform disorders. J. Abnorm. Psychol. 121:530–43 [Google Scholar]
  71. Katzer A, Oberfeld D, Hiller W, Witthöft M. 2011. Tactile perceptual processes and their relationship to medically unexplained symptoms and health anxiety. J. Psychosom. Res. 71:335–41 [Google Scholar]
  72. Kehler MD, Hadjistavropoulos HD. 2009. Is health anxiety a significant problem for individuals with multiple sclerosis?. J. Behav. Med. 32:150–61 [Google Scholar]
  73. Keijsers E, Feleus A, Miedema HS, Koes BW, Bierma-Zeinstra SM. 2010. Psychosocial factors predicted nonrecovery in both specific and nonspecific diagnoses at arm, neck, and shoulder. J. Clin. Epidemiol. 63:1370–79 [Google Scholar]
  74. Kirmayer LJ, Taillefer S. 1997. Somatoform disorders. Adult Psychopathology and Diagnosis SM Turner, M Hersen 333–83 New York: Wiley [Google Scholar]
  75. Klaus K, Rief W, Brahler E, Martin A, Glaesmer H, Mewes R. 2013. The distinction between “medically unexplained” and “medically explained” in the context of somatoform disorders. Int. J. Behav. Med. 20:161–71 [Google Scholar]
  76. Kleinstäuber M, Witthöft M, Hiller W. 2011. Efficacy of short-term psychotherapy for multiple medically unexplained physical symptoms: a meta-analysis. Clin. Psychol. Rev. 31:146–60 [Google Scholar]
  77. Kohl A, Rief W, Glombiewski JA. 2013. Acceptance, cognitive restructuring, and distraction as coping strategies for acute pain. J. Pain 14:305–15 [Google Scholar]
  78. Konnopka A, Schaefert R, Heinrich S, Kaufmann C, Luppa M. et al. 2012. Economics of medically unexplained symptoms: a systematic review of the literature. Psychother. Psychosom. 81:265–75 [Google Scholar]
  79. Kotov R, Ruggero CJ, Krueger RF, Watson D, Yuan QL, Zimmerman M. 2011. New dimensions in the quantitative classification of mental illness. Arch. Gen. Psychiatry 68:1003–11 [Google Scholar]
  80. Kupfer DJ, Kuhl EA, Regier DA. 2013. DSM-5—the future arrived. J. Am. Med. Assoc. 309:1691–92 [Google Scholar]
  81. Kuwert P, Braehler E, Freyberger HJ, Glaesmer H. 2012. More than 60 years later: the mediating role of trauma and posttraumatic stress disorder for the association of forced displacement in World War II with somatization in old age. J. Nerv. Ment. Dis. 200:911–14 [Google Scholar]
  82. Lacourt T, Houtveen J, van Doornen L. 2013. “Functional somatic syndromes, one or many?”: an answer by cluster analysis. J. Psychosom. Res. 74:6–11 [Google Scholar]
  83. Landa A, Peterson BS, Fallon BA. 2012. Somatoform pain: a developmental theory and translational research review. Psychosom. Med. 74:717–27 [Google Scholar]
  84. Leeuw M, Goossens ME, Linton SJ, Crombez G, Boersma K, Vlaeyen JW. 2007. The fear-avoidance model of musculoskeletal pain: current state of scientific evidence. J. Behav. Med. 30:77–94 [Google Scholar]
  85. Levenson JL. 2011. The somatoform disorders: 6 characters in search of an author. Psychiatr. Clin. North Am. 34:515–24 [Google Scholar]
  86. Lim SL, Kim JH. 2005. Cognitive processing of emotional information in depression, panic, and somatoform disorder. J. Abnorm. Psychol. 114:50–61 [Google Scholar]
  87. Lloyd DM, Mason L, Brown RJ, Poliakoff E. 2008. Development of a paradigm for measuring somatic disturbance in clinical populations with medically unexplained symptoms. J. Psychosom. Res. 64:21–24 [Google Scholar]
  88. Löwe B, Spitzer RL, Williams JB, Mussell M, Schellberg D, Kroenke K. 2008. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. Gen. Hosp. Psychiatry 30:191–99 [Google Scholar]
  89. Lukkahatai N, Saligan LN. 2013. Association of catastrophizing and fatigue: a systematic review. J. Psychosom. Res. 74:100–9 [Google Scholar]
  90. Marcus DK, Gurley JR, Marchi MM, Bauer C. 2007. Cognitive and perceptual variables in hypochondriasis and health anxiety: a systematic review. Clin. Psychol. Rev. 27:127–39 [Google Scholar]
  91. Martin A, Buech A, Schwenk C, Rief W. 2007. Memory bias for health related information in somatoform disorders. J. Psychosom. Res. 63:663–71 [Google Scholar]
  92. Martin A, Jacobi F. 2006. Features of hypochondriasis and illness worry in the general population in Germany. Psychosom. Med. 68:770–77 [Google Scholar]
  93. Martin A, Rief W. 2011. Relevance of cognitive and behavioral factors in medically unexplained syndromes and somatoform disorders. Psychiatr. Clin. North Am. 34:565–78 [Google Scholar]
  94. McKenzie M, Clarke DM, McKenzie DP, Smith GC. 2010. Which factors predict the persistence of DSM-IV depression, anxiety, and somatoform disorders in the medically ill three months post hospital discharge?. J. Psychosom. Res. 68:21–28 [Google Scholar]
  95. McWilliams LA, Bailey SJ. 2010. Associations between adult attachment ratings and health conditions: evidence from the National Comorbidity Survey Replication. Health Psychol. 29:446–53 [Google Scholar]
  96. Miles E, Poliakoff E, Brown RJ. 2011. Medically unexplained symptom reports are associated with a decreased response to the rubber hand illusion. J. Psychosom. Res. 71:240–44 [Google Scholar]
  97. Morley S. 2011. Efficacy and effectiveness of cognitive behaviour therapy for chronic pain: progress and some challenges. Pain 152:S99–106 [Google Scholar]
  98. Nelson S, Baldwin N, Taylor J. 2012. Mental health problems and medically unexplained physical symptoms in adult survivors of childhood sexual abuse: an integrative literature review. J. Psychiatr. Ment. Health Nurs. 19:211–20 [Google Scholar]
  99. Nijs J, Roussel N, Van Oosterwijck J, De Kooning M, Ickmans K. et al. 2013. Fear of movement and avoidance behaviour toward physical activity in chronic-fatigue syndrome and fibromyalgia: state of the art and implications for clinical practice. Clin. Rheumatol. 32:1121–29 [Google Scholar]
  100. Nikendei C, Waldherr S, Schiltenwolf M, Herzog W, Rohrig M. et al. 2009. Memory performance related to organic and psychosocial illness attributions in somatoform pain disorder patients. J. Psychosom. Res. 67:199–206 [Google Scholar]
  101. Oftedal G, Straume A, Johnsson A, Stovner LJ. 2007. Mobile phone headache: a double blind, sham-controlled provocation study. Cephalalgia 27:447–55 [Google Scholar]
  102. Olesen J, Gustavsson A, Svensson M, Wittchen HU, Jonsson B. et al. 2012. The economic cost of brain disorders in Europe. Eur. J. Neurol. 19:155–62 [Google Scholar]
  103. Pennebaker JW. 1982. The Psychology of Physical Symptoms New York: Springer
  104. Pincus T, Morley S. 2001. Cognitive-processing bias in chronic pain: a review and integration. Psychol. Bull. 127:599–61 [Google Scholar]
  105. Posserud I, Svedlund J, Wallin J, Simren M. 2009. Hypervigilance in irritable bowel syndrome compared with organic gastrointestinal disease. J. Psychosom. Res. 66:399–405 [Google Scholar]
  106. Quartana PJ, Campbell CM, Edwards RR. 2009. Pain catastrophizing: a critical review. Expert Rev. Neurother. 9:745–58 [Google Scholar]
  107. Raspe H, Hueppe A, Neuhauser H. 2008. Back pain, a communicable disease. Int. J. Epidemiol. 37:69–74 [Google Scholar]
  108. Regier DA, Narrow WE, Clarke DE, Kraemer HC, Kuramoto SJ. et al. 2013. DSM-5 field trials in the United States and Canada, part II: test-retest reliability of selected categorical diagnoses. Am. J. Psychiatry 170:59–70 [Google Scholar]
  109. Riebel K, Egloff B, Witthöft M. 2013. The implicit health-related self-concept in somatoform disorders. J. Behav. Therapy Exp. Psychiatry 44:335–42 [Google Scholar]
  110. Rief W, Avorn J, Barsky AJ. 2006a. Medication-attributed adverse effects in placebo groups. Implications for assessment of adverse effects. Arch. Intern. Med. 166:155–60 [Google Scholar]
  111. Rief W, Barsky AJ. 2005. Psychobiological perspectives on somatoform disorders. Psychoneuroendocrinology 30:996–1002 [Google Scholar]
  112. Rief W, Bingel U, Schedlowski M, Enck P. 2011a. Mechanisms involved in placebo and nocebo responses and implications for drug trials. Clin. Pharmacol. Ther. 90:722–26 [Google Scholar]
  113. Rief W, Broadbent E. 2007. Explaining medically unexplained symptoms: models and mechanisms. Clin. Psychol. Rev. 27:821–41 [Google Scholar]
  114. Rief W, Heitmüller AM, Reisberg K, Rüddel H. 2006b. Why reassurance fails in patients with unexplained symptoms—an experimental investigation of remembered probabilities. PLoS Med. 3:e269 [Google Scholar]
  115. Rief W, Hennings A, Riemer S, Euteneuer F. 2010a. Psychobiological differences between depression and somatization. J. Psychosom. Res. 68:495–502 [Google Scholar]
  116. Rief W, Hessel A, Braehler E. 2001. Somatization symptoms and hypochondriacal features in the general population. Psychosom. Med. 63:595–602 [Google Scholar]
  117. Rief W, Heuser J, Fichter MM. 1996. What does the Toronto Alexithymia Scale TAS-R measure?. J. Clin. Psychol. 52:423–29 [Google Scholar]
  118. Rief W, Isaac M. 2007. Are somatoform disorders “mental disorders”? A contribution to the current debate. Curr. Opin. Psychiatry 20:143–46 [Google Scholar]
  119. Rief W, Mewes R, Martin A, Glaesmer H, Braehler E. 2010b. Are psychological features useful in classifying patients with somatic symptoms?. Psychosom. Med. 72:648–55 [Google Scholar]
  120. Rief W, Mewes R, Martin A, Glaesmer H, Braehler E. 2011b. Evaluating new proposals for the psychiatric classification of patients with multiple somatic symptoms. Psychosom. Med. 73:760–68 [Google Scholar]
  121. Rief W, Nanke A, Emmerich J, Bender A, Zech T. 2004. Causal illness attributions in somatoform disorders: associations with comorbidity and illness behavior. J. Psychosom. Res. 57:367–71 [Google Scholar]
  122. Rief W, Nestoriuc Y, von Lilienfeld-Toal A, Dogan I, Schreiber F. et al. 2009. Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis. Drug Saf. 32:1041–56 [Google Scholar]
  123. Rief W, Rojas G. 2007. Stability of somatoform symptoms: implications for classification. Psychosom. Med. 69:864–69 [Google Scholar]
  124. Rosmalen JGM, Tak LM, de Jonge P. 2011. Empirical foundations for the diagnosis of somatization: implications for DSM-5. Psychol. Med. 41:1133–42 [Google Scholar]
  125. Ruchkin V, Schwab-Stone M. 2013. A longitudinal study of somatic complaints in urban adolescents: the role of internalizing psychopathology and somatic anxiety. J. Youth Adolesc. In press
  126. Salkovskis PM. 1995. Effective Treatment of Severe Health Anxiety (Hypochondriasis) Copenhagen: World Congress Behav. Cogn. Ther. [Google Scholar]
  127. Sattel H, Lahmann C, Gündel H, Guthrie E, Kruse J. et al. 2012. Brief psychodynamic-interpersonal psychotherapy for patients with multisomatoform disorder: a randomised controlled trial. Br. J. Psychiatry 100:60–67 [Google Scholar]
  128. Schaefer M, Egloff B, Witthöft M. 2012. Is interoceptive awareness really altered in somatoform disorders? Testing competing theories with two paradigms of heartbeat perception. J. Abnorm. Psychol. 121:719–24 [Google Scholar]
  129. Scholz B, Ott R, Sarnoch H. 2001. Proprioception in somatoform disorders. Behav. Res. Ther. 39:1429–38 [Google Scholar]
  130. Schroder A, Rehfeld E, Ornbol E, Sharpe M, Licht RW, Fink P. 2012. Cognitive-behavioural group treatment for a range of functional somatic syndromes: randomised trial. Br. J. Psychiatry 200:499–507 [Google Scholar]
  131. Schweinhardt P, Kalk N, Wartolowska K, Chessell I, Wordsworth P, Tracey I. 2008. Investigation into the neural correlates of emotional augmentation of clinical pain. NeuroImage 40:759–66 [Google Scholar]
  132. Seminovicz DA, Davis KD. 2006. Cortical responses to pain in healthy individuals depends on pain catastrophizing. Pain 120:297–306 [Google Scholar]
  133. Sørensen P, Birket-Smith M, Wattar U, Buemann I, Salkovskis P. 2010. A randomized clinical trial of cognitive behavioural therapy versus short-term psychodynamic psychotherapy versus no intervention for patients with hypochondriasis. Psychol. Med. 41:431–41 [Google Scholar]
  134. Stein MB, Barrett-Connor E. 2000. Sexual assault and physical health: findings from a population-based study of older adults. Psychosom. Med. 62:838–43 [Google Scholar]
  135. Steinbrecher N, Koerber S, Frieser D, Hiller W. 2011. The prevalence of medically unexplained symptoms in primary care. Psychosomatics 52:263–71 [Google Scholar]
  136. Taylor GJ, Bagby RM, Parker JDA. 1992. The revised Toronto Alexithymia Scale: some reliability, validity, and normative data. Psychother. Psychosom. 57:34–41 [Google Scholar]
  137. Taylor RE, Mann AH, White NJ, Goldberg DP. 2000. Attachment style in patients with unexplained physical complaints. Psychol. Med. 30:931–41 [Google Scholar]
  138. Taylor RE, Marshall T, Mann A, Goldberg DP. 2012. Insecure attachment and frequent attendance in primary care: a longitudinal cohort study of medically unexplained symptom presentations in ten UK general practices. Psychol. Med. 42:855–64 [Google Scholar]
  139. Tomenson B, Creed F. DSM-5 Population Project Group 2010. Can we diagnose somatoform disorders using all bodily symptoms rather than “medically unexplained” symptoms?. J. Psychosom. Res. 68:670 [Google Scholar]
  140. Tomenson B, Essau C, Jacobi F, Ladwig KH, Leiknes KA. et al. 2013. Total somatic symptom score as a predictor of health outcome in somatic symptom disorders. Br. J. Psychiatry 203373–80
  141. Tomenson B, McBeth J, Chew-Graham CA, MacFarlane G, Davies I. et al. 2012. Somatization and health anxiety as predictors of health care use. Psychosom. Med. 74:656–64 [Google Scholar]
  142. Tyrer P, Cooper S, Crawford M, Dupont S, Green J. et al. 2011. Prevalence of health anxiety problems in medical clinics. J. Psychosom. Res. 71:392–94 [Google Scholar]
  143. Vernia P, Di Camillo M, Foglietta T, Avallone VE, De Carolis A. 2013. Diagnosis of lactose intolerance and the “nocebo” effect: the role of negative expectations. Dig. Liver Dis. 42:616–19 [Google Scholar]
  144. Vlaeyen JWS, Linton SJ. 2000. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain 85:317–32 [Google Scholar]
  145. Voigt K, Nagel A, Meyer B, Langs G, Braukhaus C, Löwe B. 2010. Towards positive diagnostic criteria: a systematic review of somatoform disorder diagnoses and suggestions for future classification. J. Psychosom. Res. 68:403–14 [Google Scholar]
  146. Voigt K, Wollburg E, Weinmann N, Herzog A, Meyer B. et al. 2012. Predictive validity and clinical utility of DSM-5 somatic symptom disorder—comparison with DSM-IV somatoform disorders and additional criteria for consideration. J. Psychosom. Res. 73:345–50 [Google Scholar]
  147. Wade JB, Riddle DL, Price DD, Dumenci L. 2011. Role of pain catastrophizing during pain processing in a cohort of patients with chronic and severe arthritic knee pain. Pain 152:314–19 [Google Scholar]
  148. Warren JW, Clauw DJ. 2012. Functional somatic syndromes: sensitivities and specificities of self-reports of physician diagnosis. Psychosom. Med. 74:891–95 [Google Scholar]
  149. Warren JW, Langenberg P, Clauw DJ. 2013. The number of existing functional somatic syndromes (FSSs) is an important risk factor for new, different FSSs. J. Psychosom. Res. 74:12–17 [Google Scholar]
  150. Watson D, Pennebaker JW. 1989. Health complaints, stress, and distress: exploring the central role of negative affectivity. Psychol. Rev. 96:234–54 [Google Scholar]
  151. Wetherell JL, Afari N, Rutledge T, Sorrell JT, Stoddard JA. et al. 2011. A randomized, controlled trial of acceptance and commitment therapy and cognitive-behavioral therapy for chronic pain. Pain 152:2098–107 [Google Scholar]
  152. White PD. 2013. Functional somatic syndromes may be either “polysyndromic” or “monosyndromic.”. J. Psychosom. Res. 74:2–3 [Google Scholar]
  153. Wingenfeld K, Terfehr K, Meyer B, Löwe B, Spitzer C. 2013. Memory bias for emotional and illness-related words in patients with depression, anxiety and somatization disorders: an investigation with the directed forgetting task. Psychopathology 46:22–27 [Google Scholar]
  154. Witthöft M, Hiller W. 2010. Psychological approaches to origins and treatments of somatoform disorders. Annu. Rev. Clin. Psychol. 6:257–83 [Google Scholar]
  155. Witthöft M, Rubin GJ. 2013. Are media warnings about the adverse health effects of modern life self-fulfilling? An experimental study on idiopathic environmental intolerance attributed to electromagnetic fields (IEI-EMF). J. Psychosom. Res. 74:206–12 [Google Scholar]
  156. Wollburg E, Voigt K, Braukhaus C, Herzog A, Lowe B. 2013. Construct validity and descriptive validity of somatoform disorders in light of proposed changes for the DSM-5. J. Psychosom. Res. 74:18–24 [Google Scholar]

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error